Latest Respiratory and pulmonary system biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Why do we get reinfected with COVID-19? A new study identifies the 5 main causes

by IrsiCaixa

11 months ago
COVID-19

The Fight Infections Foundation and IrsiCaixa, in collaboration with the Germans Trias Hospital, have published a study indicating that the main cause of reinfections is viral evolution

Can artificial intelligence outperform experts in mechanical ventilation?

by Instituto de Investigación e Innovación Parc Taulí

11 months ago
artificial intelligence, mechanical ventilation, large language models (LLMs)

I3PT team demonstrates the potential of language models to accelerate the creation of vital diagnostic tools

One of the Possible Causes of Chronic Fatigue in People with Long COVID Identified

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

11 months ago
Chronic Fatigue, Long COVID, fibrosis

Fatigue in long COVID patients may be related to fibrosis caused by the infection in the walls of blood vessels. This would hinder the delivery of oxygen to muscle fibers and limit the capacity for pr...

Progress Toward a Population Screening Test for COPD

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

11 months ago
Chronic Obstructive Pulmonary Disease (COPD)

70% of Chronic Obstructive Pulmonary Disease (COPD) cases go undiagnosed. Now, a study led by Hospital del Mar and the Hospital del Mar Research Institute has validated ten metabolites that are altere...

A new study opens the door to improving treatment for rheumatoid arthritis with lung involvement

by Instituto de Investigación Marqués de Valdecilla

10 months ago
baricitinib, rheumatoid arthritis and associated pulmonary fibrosis

A team of rheumatology specialists from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Health Research Institute (IDIVAL) has participated in a national multicent...

Respiratory symptoms during the stable phase of bronchiectasis are a key factor in prognosis and response to treatment

by Fundació Clínic per a la Recerca Biomèdica

10 months ago
bronchiectasis, macrolides

Researchers from the Clinic-IDIBAPS lead an international study, published in The Lancet Respiratory Medicine, which demonstrates the importance of respiratory symptoms in prognosis and treatment resp...

WLCC2025: An innovative targeted therapy shows promising results in the treatment of lung cancer with ROS1 gene alterations

by VHIO

10 months ago
ROS1 gene, non-small cell lung cancer (NSCLC), zidesamtinib

Results from the international Phase 1/2 clinical trial ARROS-1 show promising outcomes with zidesamtinib, a novel ROS1 selective inhibitor under investigation, in patients with advanced non-small cel...

New Research Group TRAIL Launched to Drive Innovation in Thoracic Surgery and Lung Cancer

by Hospital de la Santa Creu i Sant Pau

10 months ago
TRAIL (Thoracic Surgery Research and Innovation in Lung Cancer)

Its main lines of research include early diagnosis of lung cancer through screening programs and advanced imaging techniques; optimal surgical selection after induction treatments; improvement of surg...

New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis

by CNIO - Centro Nacional de Investigaciones Oncológicas

10 months ago
POT1 gene, Idiopathic pulmonary fibrosis, ‘telomere syndromes’, shelterins, Telomeres

A research group from the National Cancer Research Centre (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult.

Un estudio en el que ha participado la ULE demuestra que el virus de la gripe porcina modifica la microbiota pulmonar

by Universidad de León

10 months ago
microbiota pulmonar, virus de la gripe porcina

Las infecciones por gripe alteran la microbiota pulmonar y potencian la aparición de patógenos oportunistas

Una quincena de profesionales de Vall d’Hebron participan en la elaboración de una guía para el diagnóstico y seguimiento de la ataxia telangiectasia

by Vall d’Hebron

9 months ago
Ataxia Telangiectasia, Vall d’Hebron

Se trata de una enfermedad minoritaria de origen genético caracterizada por dificultades progresivas en la coordinación motora, infecciones recurrentes y predisposición al cáncer.

Células asesinas contra el cáncer de pulmón más agresivo

by CIMA - Centro de Investigación Médica Aplicada

9 months ago
linfocitos ‘natural killer’, CCL5, cáncer de pulmón

Investigadores del Cima Universidad de Navarra demuestran que una nueva estrategia para activar linfocitos ‘natural killer’ disminuye significativamente el tumor en modelos animales